News
Merial Announces Introduction of EQUIOXX® (firocoxib) Injection
Overall NSAID Use
Stride
ApHC
Equioxx is Official Product of the AQHA
AQHA Approves Equioxx
USEF Approves Equioxx® (firocoxib)
Editors, reporters, writers, producers and other members of the news media seeking additional information and/or press materials for EQUIOXX (firocoxib) should contact the following individuals:
Natasha Mahanes
Merial Limited
678-638-3681
Natasha.Mahanes@merial.com
Kelly Goss
Sullivan Higdon & Sink
816-283-4730
kelly.goss@shscom.com
Veterinarians, horse owners, and equine health care managers with questions about EQUIOXX should call Merial Customer Care at
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,400 people and operates in more than 150 countries worldwide. Its 2008 sales were over $2.6 billion. Merial Limited is a joint venture between Merck & Co., Inc. and sanofi-aventis. For more information, please see www.merial.com.
